60 SVR12 RATES AND SAFETY OF TRIPLE THERAPY INCLUDING TELAPREVIR OR BOCEPREVIR IN 221 CIRRHOTIC NON RESPONDERS TREATED IN THE FRENCH EARLY ACCESS PROGRAM (ANRS CO20-CUPIC)

Fontaine, H.; Hezode, C.; Dorival, C.; Larrey, D.; Zoulim, F.; De Ledinghen, V.; Canva, V.; Alric, L.; Bourlière, M.; Pol, S.; Poynard, T.; Riachi, G.; Bernard, P.-H.; Raabe, J.-J.; Gournay, J.; Métivier, S.; Pawlotsky, J.-M.; Samuel, D.; Barthe, Y.; Carrat, F.; Bronowicki, J.-P.

期刊名称Journal of Hepatology
作者Fontaine, H.; Hezode, C.; Dorival, C.; Larrey, D.; Zoulim, F.; De Ledinghen, V.; Canva, V.; Alric, L.; Bourlière, M.; Pol, S.; Poynard, T.; Riachi, G.; Bernard, P.-H.; Raabe, J.-J.; Gournay, J.; Métivier, S.; Pawlotsky, J.-M.; Samuel, D.; Barthe, Y.; Carrat, F.; Bronowicki, J.-P.
卷第58卷
印刷ISSN0168-8278
文件大小55.87KB
发表时间2013-04
DOI10.1016/S0168-8278(13)60062-8

发现好书期刊，享受阅读乐趣

60 SVR12 RATES AND SAFETY OF TRIPLE THERAPY INCLUDING TELAPREVIR OR BOCEPREVIR IN 221 CIRRHOTIC NON RESPONDERS TREATED IN THE FRENCH EARLY ACCESS PROGRAM (ANRS CO20-CUPIC)